NewGenIvf Group Limited (NIVF)
| Market Cap | 1.97M -40.0% |
| Revenue (ttm) | 4.63M -13.0% |
| Net Income | 1.12M |
| EPS | 2.19 |
| Shares Out | 27.30M |
| PE Ratio | 0.03 |
| Forward PE | 0.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,393,227 |
| Open | 0.0787 |
| Previous Close | 0.0811 |
| Day's Range | 0.0680 - 0.0787 |
| 52-Week Range | 0.0636 - 1,539.0000 |
| Beta | 0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 12, 2026 |
About NIVF
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring servi... [Read more]
Financial Performance
Financial StatementsNews
NewGen Announces Closing of $1.25 Million Public Offering
BANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through ...
NewGenIvf Group prices 17.86M ordinary shares at 7c
NewGenIvf Group (NIVF) announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the company expected to be approximately $1.25M, before deducting…
NewGen Announces Pricing of $1.25 Million Public Offering
BANGKOK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through...
NewGenIvf Group Ltd trading halted, news pending
19:50 EDT NewGenIvf Group (NIVF) Ltd trading halted, news pending
NewGenIvf Group files to sell Class A ordinary shares, no amount given
The placement agent for this offering is Aegis Capital.
NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor
BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an...
NewGen Provides Update on K25.ai Investment and Strengthened Financial Position
NewGen's total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization NewGen's agreed 13% stake in K25.ai is now valued at...
NewGenIvf Group to buy additional 3% of K25.ai at $250M valuation
NewGenIVF announced a definitive agreement to acquire an additional 3% equity interest in K25.ai at a $250M equity valuation. The $7.5M investment follows K25.ai’s community beta launch. Upon completi...
NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million
Follow-on investment would increase NewGen's aggregate ownership to 13% Follow-on investment would increase NewGen's aggregate ownership to 13%
NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million
K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million NewGen's 10% ownership stake in K25.ai has reached US$20 million in value and generated a ~US$10 million unre...
NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million
Midpoint equity value for planned UAE cell sorting entity highlights significant growth runway in high-infertility, medical-tourism hotspot
NewGenIvf Group Ltd trading halted, news pending
19:50 EDT NewGenIvf Group (NIVF) Ltd trading halted, news pending
NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
Strong Capitalization Foundation Supports Strategic Growth and Market Stability Strong Capitalization Foundation Supports Strategic Growth and Market Stability
NewGenIvf Group increases K25.ai ownership to 10%
NewGenIVF Group (NIVF) announced that it has executed an agreement for a further $4M strategic investment in K25.ai. The transaction completes K25.ai’s $10M Pre-A round at a $100M valuation and,…
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion
NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure
NewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure
NewGenIvf Group commits additional $6M investment in K25.ai market platform
NewGenIVF Group (NIVF) has committed an additional $4M strategic investment in K25.ai, an AI-native livestreaming and watch-to-predict prediction market platform purpose-built for Asia-Pacific, bringi...
NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy
NewGen's 6% Stake in K25.ai Now Valued at US$6 Million Company will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- New...
NewGenIvf Group to acquire 2% equity interest in K25.ai for $2M
NewGenIVF Group (NIVF) announced that it has executed a share purchase agreement and an exclusive agency agreement with K25.ai. Under the share purchase agreement, NewGen will acquire an initial 2%…
NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung
NewGen executes Share Purchase Agreement to acquire an initial 2% equity interest in K25.ai, with the right to invest up to 10% in total NewGen also executes Exclusive Agency Agreement with K25.ai, ap...
K25.ai, Led by Tech Veteran Andy Cheung, Eyes Public Listing as World's First Prediction Market After $100M Valuation Investment from Nasdaq-Listed Strategic Partner
Nasdaq-listed NIVF has made an initial US$2 million strategic investment in K25.ai (with an option for up to US$10M). K25.ai co-founders will join NIVF's board to support deeper strategic alignment, a...
NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation
BANGKOK and SINGAPORE, May 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGenIVF” or the “Company”), a technology-driven, diversified growth company, today announced that it ...
NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress
NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Gr...
NewGenIvf Group Ltd trading halted, news pending
19:50 EDT NewGenIvf Group (NIVF) Ltd trading halted, news pending
NewGenIvf Group files to sell 100M Class A ordinary shares for holders
17:32 EST NewGenIvf Group (NIVF) files to sell 100M Class A ordinary shares for holders